Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-25-009485
Filing Date
2025-03-27
Accepted
2025-03-27 08:35:33
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 clnn20250313_424b5.htm 424B5 391029
2 clenelogo11percent.jpg GRAPHIC 10252
3 clnn20230216_424b5img004.jpg GRAPHIC 44394
4 pipelinejan2025_22pct.jpg GRAPHIC 109216
  Complete submission text file 0001437749-25-009485.txt   618176
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-264299 | Film No.: 25775461
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)